Hualan Biological Vaccine Inc. | Pharmaceutical Manufacturer Profile & Drug Portfolio

Influenza virus split vaccine

The composition of this vaccine is in line with the strains recommended by WHO for the current year. Each dose of vaccine contains three strains of antigens: type A1, type A3, and type B. Type A1 (New Caledonia/20/99 (H1N1) reassortant [IVR-116 strain]) Hemagglutinin content: ge; 12mu; g Type A3 (Fujian/41I/02 (H3N2) similar strain [NYMCX-147 strain]) Hemagglutinin content: ge; 12mu; g Type B (B/Shanghai/36I/02 similar strain [B/Jiangsu/10/2003 strain]) Hemagglutinin content: ge; 12mu; g

Name	Description	Content
Type A1 (New Caledonia/20/99 (H1N1) reassortant [IVR-116 strain])	Inducing immune response against influenza virus and reducing influenza morbidity More Inducing immune response against influenza virus and reducing influenza morbidity	ge;12mu;g
Type A3 (Fujian/41I/02(H3N2) similar strain [NYMCX-147 strain])	Inducing immune response against influenza virus and reducing influenza morbidity More Inducing immune response against influenza virus and reducing influenza morbidity	ge;12mu;g
Type B (similar strains of B/Shanghai/36I/02 [B/Jiangsu/10/2003])	Inducing immune response against influenza virus and reducing influenza morbidity More Inducing immune response against influenza virus and reducing influenza morbidity	ge;12mu;g

ACYW135 group meningococcal polysaccharide vaccine

Name	Description	Content	CAS NO.	Registered Holders
ACYW135 group meningococcal polysaccharide	No specific description of pharmacological action is clear from the information More No specific description of pharmacological action is clear from the information			0

Influenza virus split vaccine

The composition of this vaccine is in line with the strains recommended by WHO for the current year. Each dose of vaccine contains three strains of antigens: type A1, type A3, and type B. Type A1 (New Caledonia/20/99 (H1N1) reassortant [IVR-116 strain]) Hemagglutinin content: ge; 12mu; g Type A3 (Fujian/41I/02 (H3N2) similar strain [NYMCX-147 strain]) Hemagglutinin content: ge; 12mu; g Type B (B/Shanghai/36I/02 similar strain [B/Jiangsu/10/2003 strain]) Hemagglutinin content: ge; 12mu; g

Name	Description	Content
Type A1 (New Caledonia/20/99 (H1N1) reassortant [IVR-116 strain])	Inducing immune responses to protect against influenza virus infection More Inducing immune responses to protect against influenza virus infection	≥12μg
Type A3 (Fujian/41I/02(H3N2) similar strain [NYMCX-147 strain])	Inducing immune responses to protect against influenza virus infection More Inducing immune responses to protect against influenza virus infection	≥12μg
Type B (similar strains of B/Shanghai/36I/02 [B/Jiangsu/10/2003])	Inducing immune responses to protect against influenza virus infection More Inducing immune responses to protect against influenza virus infection	≥12μg

Recombinant Hepatitis B Vaccine (Hansenula)

Name	Description	Content	CAS NO.	Registered Holders
Recombinant Hepatitis B Vaccine (Hansenula) Lyophilized Reference	No specific description of pharmacological action is clear from the above information More No specific description of pharmacological action is clear from the above information			0

Recombinant Hepatitis B Vaccine (Hansenula)

Name	Description	Content	CAS NO.	Registered Holders
Recombinant Hepatitis B Vaccine (Hansenula) Lyophilized Reference	Extract the name, type (main ingredient or excipient), content, unit, and pharmacological action of the raw material from the above information More Extract the name, type (main ingredient or excipient), content, unit, and pharmacological action of the raw material from the above information			0